PPARA and Disorder of lipid metabolism: A single dose of the synthetic PPARα agonist WY14643 (WY, 80 mg/kg, i.p.)or chronic administration of fenofibrate, clinically available for lipid metabolism disorders, in the diet (0.2%) for 14 days significantly reduced or abolished behavioral and EEG expressions of nicotine-induced seizures.